On April 14, 2022, the following persons resigned from the following positions from CEN Biotech, Inc. Bahige (Bill) Chaaban resigned from his positions as President, Chairman of the Board of Directors Company effective at the close of business on April 14, 2022. Alex Tarrabain resigned from his positions as the Company's Director effective at the close of business on April 14, 2022. Rick Purdy resigned from his positions as Company's Senior Vice President of Deals and Acquisitions and Director effective at the close of business on April 14, 2022.

Amen Ferris resigned from his positions as Company's Vice President and Director effective at the close of business on April 14, 2022. Joseph Byrne resigned from his positions as a Director of the Company effective at the close of business on April 14, 2022. Additionally, Richard Boswell resigned from his positions as the Company's Senior Executive Vice President and Director effective as of April 15, 2022.

On April 14, 2022, the Company's Board of Directors (the “Board”) appointed Brian S. Payne as the Company's Chairman of the Board of Directors and appointed Lawrence Lehoux as the Company's President, effective at the close of business on April 14, 2022. Brian Payne, age 54, has served as the Company's Vice President and a member of ourBoard since July 2017. Mr. Payne also worked for the Company since July 2015 as marketing consultant.

Lawrence Lehoux, age 50, has served as the Company's Chief Technology Officer and a member of the Board of Directors since July 9, 2021. Lawrence Lehoux has served as the Chief Executive Officer of CMM since April 2017 and continues to serve in such capacity to date.